Who we are
‘Who we are’ provides information about the management, governance and ownership structure of Novo Nordisk.
Here you will also find a welcome letter by By Lars Rebien Sørensen, President and CEO and by Sten Scheibye, Chairman of the Board of Directors.
Or get an insight into the history of Novo Nordisk. Our strong background in diabetes care builds on more than 80 years’ experience in this area. It began in 1922 when August Krogh, Danish Nobel laureate in physiology, and his wife, Marie, who had type 2 diabetes, visited Professor J J R Macleod, head of the institute in Toronto, where the world’s first insulin extract had been produced.
